Recordati Industria Chimica e Farmaceutica S.p.A. Competitors

Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts Market Cap
AZN AstraZeneca PLC Outperform 17
£121.70 £165.99 33.89% 16 £188.66B
ABT Abbott Laboratories Outperform 9
$106.29 $118.92 19.01% 7 $184.43B
PFE Pfizer Outperform 2
$27.18 $32.87 12.21% 6 $153.91B
4502 Takeda Pharmaceutical Company Outperform 5
¥4.14k ¥4.74k 9.82% 0 ¥6.50T
ARGX argenx Outperform 4
350.80€ 531.81€ 24.86% 10 20.83€B
GMAB Genmab A/S Outperform 16
kr1.97k kr2.71k 33.81% 14 kr127.11B
VTRS Viatris Inc Hold 8
$11.63 $11.73 3.18% 5 $13.74B
IPN Ipsen Hold 17
114.10€ 127.95€ 5.17% 0 9.42€B
CHDN Churchill Downs Buy 16
$129.83 $143.67 11.68% 2 $9.48B
ZEAL Zealand Pharma A/S Outperform 8
kr630.00 kr357.00 29.37% 2 kr39.42B
ORNBV Orion Oyj Hold 14
35.79€ 42.52€ 17.35% 3 5.04€B
HIK Hikma Pharmaceuticals PLC Outperform 18
£19.35 £28.11 50.96% 9 £4.27B
ALK B ALK-Abelló A/S Outperform 13
kr131.20 kr109.25 1.37% 3 kr28.87B
ALRM Alarm.com Holdings Outperform 16
$66.90 $67.13 23.47% 7 $3.34B
BHC Bausch Health Companies Hold 15
$8.75 $9.50 8.57% 5 $3.21B
VIRP Virbac Outperform 18
347.00€ 348.34€ 6.34% 5 2.90€B
MOR MorphoSys Outperform 6
66.20€ 28.78€ 2.72% 3 2.49€B
PENN PENN Entertainment Outperform 13
$16.44 $29.89 52.07% 1 $2.52B
INDV Indivior PLC Buy 14
£14.28 £28.89 118.77% 4 £1.95B
CORT Corcept Therapeutics Buy 16
$23.88 $35.67 59.13% 4 $2.48B
ALM Almirall Outperform 16
8.57€ 11.39€ 28.35% 3 1.79€B
EVT Evotec Outperform 14
9.74€ 37.33€ 161.81% 4 1.73€B
COPN Cosmo Pharmaceuticals N.V. Buy 12
CHF72.30 CHF76.55 29.41% 0 CHF1.16B
FAE Faes Farma Hold 18
3.41€ 3.90€ 7.04% 0 1.06€B
MERC Mercer International Hold 14
$10.24 $8.63 2.54% 4 $676.64M
PHM Pharma Mar Outperform 13
30.44€ 50.20€ 57.69% 1 536.95€M
SFA Sopharma AD Buy 14
лв6.02 лв6.96 18.60% 0 лв997.04M
BSLN Basilea Pharmaceutica Outperform 6
CHF39.50 CHF65.63 67.09% 0 CHF474.13M
XERS Xeris Biopharma Holdings Buy 6
$1.75 $4.60 171.43% 1 $244.39M
DBV DBV Technologies Outperform 5
1.24€ 4.07€ 222.58% 1 119.30€M
MOLN Molecular Partners Outperform 4
CHF3.29 CHF9.50 184.19% 1 CHF110.77M